Contract Manufacturing The managing director of Encube Ethicals discusses contract manufacturing in India today, growing competition from China, and partnering with the world’s leading multinational pharma companies. Mr Dilip Shah from the Indian Pharmaceutical Alliance told us that the main strength of India is manufacturing, so of course, contract manufacturing as…
Quintiles India Quintiles first established its operations in India in 1997, which was a very early stage in clinical research. What have been the main changes undergone by the country since then? When Quintiles established operations in India in 1997 via a joint venture, it redefined the CRO industry. Prior to this,…
Cyprus Standing at the crossroads of three continents, Cyprus embodies the beauty and diversity of Mediterranean culture. Being tucked beneath Turkey and hugging the western shores of the Middle East gives a distinct eastern feel to the island nation. Yet the country leans strongly west as a full-fledged member of the…
Novartis India Right after you started heading the India operations roughly 15 years ago, you had to oversee one the biggest mergers in the industry at that time. How challenging was that moment for you? Any merger has its set of challenges and opportunities, and I think you will always look more…
Ferring Russia Ferring is a specialty biopharmaceutical company that operates in four strategic therapeutic areas. Globally, many pharma companies have been diversifying their portfolio, and entering the OTC segment, generics segment, medical device segment, etc. But Ferring does not deviate from its core business anywhere in the world. What is the value…
Ferring Pharmaceuticals UK Shire’s International Marketing to being COO of start-up medical device company, Medicsight. What about Ferring and your current role attracted you to take this job and what are you bringing on board that is unique from your past experiences? As you mentioned, I have quite an extensive career and would…
Novo Nordisk Hungary We understand that you have been with Novo Nordisk for quite a while already. In the past decade, you also did not sit still in terms of location, working in different international contexts. Can you give our readers some background on the market environment when you first started heading the…
Lundbeck Russia Lundbeck is a niche player exclusively focused on the treatment of CNS and mental health disorders. How developed do you find this niche to be in Russia? The size of this niche is relatively small in Russia, when compared to Western Europe and other developed regions. In Russia, we are…
AstraZeneca Serbia As the 7th largest pharma MNC worldwide, AstraZeneca is a company that needs no introduction. However, our readers would love to hear more about your operations here in Serbia… Therefore, can you please first provide them with an idea of the key milestones for the company in Serbia, since you…
Lupin Pharmaceuticals Inc. Two weeks ago, Lupin announced its annual results, portraying 6 years of sustained growth and a net profit up by 27%. How pleased were you with this performance, and were you expecting such strong results? We were pleased, but not very pleased. We thought that we could have done much…
Astellas Russia When our team interviewed Amit Makwana at Astellas’ European Headquarters in the UK, he noted that the Russian affiliate is experiencing a huge growth rate that is very difficult for the rest of the European business to keep up with. All eyes are on you. Do you feel the envy…
Janssen Serbia How does Janssen view the Serbian market today, and how has company built up its presence here in the country? Previously we were working through distribution channels and in 2003 we started to operate as a part of Johnson & Johnson in Serbia. As you know J&J has three parts:…
See our Cookie Privacy Policy Here
